Research directory

Evidence before momentum.

Approved weight-management therapies appear first, followed by investigational and early-stage profiles. Use the filters to explore the full directory.

Peptide intelligence

Explore the evidence.

Original Senzu profiles built from regulator documents, clinical registries, and peer-reviewed research—not retail claims.

Evidence-first, not hype-first.Approved weight-management options appear before experimental compounds. Approval, human evidence, and laboratory findings stay separate.

Search the directory

12 of 12 profiles

High evidenceFDA approved

Semaglutide

Weight management and cardiovascular risk

3primary sources indexed

High evidenceFDA approved

Tirzepatide

Weight management and obesity-related sleep apnea

2primary sources indexed

High evidenceFDA approved

Liraglutide

Weight management and type 2 diabetes

2primary sources indexed

Moderate evidenceInvestigational

Retatrutide

Investigational weight-management therapy

2primary sources indexed

Very low evidenceNot FDA approved

MOTS-c

Metabolic signaling and longevity research

3primary sources indexed

High evidenceFDA approved

Tesamorelin

HIV-associated lipodystrophy

3primary sources indexed

Mixed evidenceFDA approved

Elamipretide

Barth syndrome and mitochondrial research

3primary sources indexed

Low evidenceNot FDA approved

CJC-1295

Growth hormone and IGF-1 pharmacology

2primary sources indexed

Low evidenceNot FDA approved

Ipamorelin

Growth hormone and gastrointestinal motility

3primary sources indexed

Very low evidenceNot FDA approved

GHK-Cu

Collagen and extracellular-matrix research

2primary sources indexed

Very low evidenceNot FDA approved

BPC-157

Musculoskeletal and gastrointestinal research

2primary sources indexed

Very low evidenceNot FDA approved

TB-500

Cell migration and wound-repair research

3primary sources indexed